China Health Care Stock Performance
| CMIM Stock | USD 0.0002 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and China Health are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days China Health Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, China Health is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
China |
China Health Relative Risk vs. Return Landscape
If you would invest 0.02 in China Health Care on September 28, 2025 and sell it today you would earn a total of 0.00 from holding China Health Care or generate 0.0% return on investment over 90 days. China Health Care is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than China, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as China Health Care, and traders can use it to determine the average amount a China Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CMIM |
Based on monthly moving average China Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Health by adding China Health to a well-diversified portfolio.
China Health Fundamentals Growth
China Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of China Health, and China Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Pink Sheet performance.
| Return On Asset | -0.73 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 9.03 M | |||
| Shares Outstanding | 4.18 M | |||
| Price To Sales | 0.01 X | |||
| Revenue | 545.88 K | |||
| EBITDA | (1.31 M) | |||
| Cash And Equivalents | 26.63 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 3.11 M | |||
| Book Value Per Share | (1.35) X | |||
| Cash Flow From Operations | (1.46 M) | |||
| Earnings Per Share | (0.29) X | |||
| Total Asset | 1.5 M | |||
About China Health Performance
By examining China Health's fundamental ratios, stakeholders can obtain critical insights into China Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that China Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Changming Industrial Management Group Holding provides hospital management consultancy services to VIP maternity and gynecological centers in China. Changming Industrial Management Group Holding was founded in 2001 and is based in Wan Chai, Hong Kong. Changming Industrial is traded on OTC Exchange in the United States.Things to note about China Health Care performance evaluation
Checking the ongoing alerts about China Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for China Health Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Health Care generated a negative expected return over the last 90 days | |
| China Health Care has some characteristics of a very speculative penny stock | |
| China Health Care has high likelihood to experience some financial distress in the next 2 years | |
| China Health Care currently holds 3.11 M in liabilities. China Health Care has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist China Health until it has trouble settling it off, either with new capital or with free cash flow. So, China Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Health Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Health's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 545.88 K. Net Loss for the year was (2.7 M) with profit before overhead, payroll, taxes, and interest of 377.77 K. | |
| China Health Care currently holds about 26.63 K in cash with (1.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing China Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Health's stock is overvalued or undervalued compared to its peers.
- Examining China Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Health's pink sheet. These opinions can provide insight into China Health's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.